Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders

Blood. 1995 Oct 1;86(7):2463-74.

Authors

M S Tallman¹, D Hakimian

Affiliation

¹ Robert H. Lurie Cancer Center of Northwestern University, Northwestern University Medical School, Chicago, IL 60611, USA.

PMID: 7670093

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / therapeutic use*
Cladribine / adverse effects
Cladribine / pharmacokinetics
Cladribine / pharmacology
Cladribine / therapeutic use
Clinical Trials as Topic
Drug Resistance
Humans
Lymphoproliferative Disorders / drug therapy*
Pentostatin / adverse effects
Pentostatin / pharmacokinetics
Pentostatin / pharmacology
Pentostatin / therapeutic use
Purine Nucleosides / therapeutic use*
Vidarabine / adverse effects
Vidarabine / analogs & derivatives
Vidarabine / pharmacokinetics
Vidarabine / pharmacology
Vidarabine / therapeutic use

Substances

Antineoplastic Agents
Purine Nucleosides
Pentostatin
Cladribine
Vidarabine
fludarabine